These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008). Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511 [TBL] [Abstract][Full Text] [Related]
5. The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival. Vitali F; Wein A; Rath T; Eckstein M; Neufert C; Siebler J; Atreya R; Hartmann A; Hohenberger W; Weber K; Neurath MF; Grützmann R; Merkel S Int J Colorectal Dis; 2022 Feb; 37(2):381-391. PubMed ID: 34865179 [TBL] [Abstract][Full Text] [Related]
6. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study. Thicoïpé A; Laharie D; Smith D; Chabrun E; Rullier A; Poullenot F; Rullier E; Denost Q Int J Colorectal Dis; 2018 Jul; 33(7):963-966. PubMed ID: 29675590 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011. Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371 [TBL] [Abstract][Full Text] [Related]
8. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Ali RA; Dooley C; Comber H; Newell J; Egan LJ Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283 [TBL] [Abstract][Full Text] [Related]
9. Increased incidence of prolonged ileus after colectomy for inflammatory bowel diseases under ERAS protocol: a cohort analysis. Dai X; Ge X; Yang J; Zhang T; Xie T; Gao W; Gong J; Zhu W J Surg Res; 2017 May; 212():86-93. PubMed ID: 28550927 [TBL] [Abstract][Full Text] [Related]
10. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study. Bogach J; Pond G; Eskicioglu C; Seow H Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449 [TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer. Reynolds IS; O'Toole A; Deasy J; McNamara DA; Burke JP Int J Colorectal Dis; 2017 Apr; 32(4):443-451. PubMed ID: 28078433 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease. Axelrad J; Kriplani A; Ozbek U; Harpaz N; Colombel JF; Itzkowitz S; Holcombe RF; Ang C Clin Colorectal Cancer; 2017 Sep; 16(3):e205-e210. PubMed ID: 27742264 [TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience. Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662 [TBL] [Abstract][Full Text] [Related]
14. Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits. Chang BW; Kumar AM; Koyfman SA; Kalady M; Lavery I; Abdel-Wahab M Int J Colorectal Dis; 2015 Mar; 30(3):403-8. PubMed ID: 25564345 [TBL] [Abstract][Full Text] [Related]